Cancer Risk in Women Treated with Fertility Drugs According to Parity Status--A Registry-based Cohort Study
Conclusions: Clomiphene citrate appears associated with increased risk of ovarian and endometrial cancer. Elevations in risks of breast and thyroid cancer were less consistent across type of drug exposure and parity.
Impact: Continued monitoring of fertility treatments is warranted. Cancer Epidemiol Biomarkers Prev; 26(6); 953–62. ©2017 AACR.
Source: Cancer Epidemiology Biomarkers and Prevention - Category: Cancer & Oncology Authors: Reigstad, M. M., Storeng, R., Myklebust, T. A., Oldereid, N. B., Omland, A. K., Robsahm, T. E., Brinton, L. A., Vangen, S., Furu, K., Larsen, I. K. Tags: Research Articles Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cervical Cancer | Clomid | Colorectal Cancer | Databases & Libraries | Endometrial Cancer | Epidemiology | Melanoma | Ovarian Cancer | Ovaries | Reproduction Medicine | Skin Cancer | Study | Thyroid | Thyroid Cancer | Women